JW Jungwoo Pharmaceutical has newly appeared among the top searched stocks.
As of 2:30 PM on the 22nd, JW Jungwoo Pharmaceutical is trading at 36,650 KRW, down 4.06% from the previous day. This represents a 10.17% decline compared to September 18. JW Jungwoo Pharmaceutical is known as a leading pharmaceutical company in the industry, famous for its infusion solutions.
Today, foreigners have been tentatively recorded as net sellers of 6,743 shares. Over the past five days, individual investors have been net buyers of 9,432 shares, while foreigners and institutions have been net sellers of 4,120 shares and net buyers of 1,178 shares, respectively.
On September 21, JW Jungwoo Pharmaceutical was a market topic with the headline, "'Actemra' lowers COVID-19 mortality rate, driving upward trend."


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
